Regulatory & Legal

The tech-powered hair tool brand, a TikTok sensation, just launched on Ulta.com. Can its viral hype translate into mainstream success and brand longevity?

A landmark acquisition aims to fix trial diversity and access by moving research from far-off labs into your neighborhood doctor's office. Here's why it matters.

AE Industrial’s latest promotions signal a deeper strategy, leveraging homegrown expertise to navigate the complex aerospace and national security investment landscape.

GMMB promotes digital strategist Erica Monteith and ad maker Jodi Quintero, signaling a deep investment in data-driven innovation and powerful advocacy.

Mahindra's new electric SUVs are getting a brain boost with indie's AI software, going beyond crash tests to proactively monitor drivers and occupants.

With key FCC and CE certifications, Vuzix begins shipping its new AI-powered LX1 smart glasses, targeting a logistics market ripe for a tech upgrade.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

Shipbroker Vantage Corp launches tech subsidiary Hadō Pte Ltd, betting on its Opswiz software to navigate the future of digital maritime logistics.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

An exclusive FDA invite positions IKE Tech’s blockchain-based age-gating system at the heart of future vape regulation, a move that could redefine the industry.

Nasdaq-listed Zeta Network Group is exploring real-world asset tokenization, signaling a pivotal move beyond Bitcoin for institutional treasury management.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

For the second straight year, Collette Health is #1 in virtual care. Discover how its integrated platform is redefining hospital efficiency and patient safety.

After uniting nine acquired firms under one brand, NowVertical is shifting its focus to organic growth, leveraging integrated operations to exceed targets.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

Thousands, including minors, were secretly filmed in Northwell Health bathrooms. A new lawsuit exposes the breach and a year-long notification delay.

Six months in, SK Telecom's Haein GPU cluster is more than a service; it's the national infrastructure engine driving South Korea's AI sovereignty.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?